LBF20207PG30: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
|SysName=9-oxo-11alpha,15S,20-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |SysName=9-oxo-11alpha,15S,20-trihydroxy-prosta-5Z,13E-dien-1-oic acid | ||
|Common Name=&&20-hydroxy Prostaglandin E_2&&9-oxo-11alpha,15S,20-trihydroxy-prosta-5Z,13E-dien-1-oic acid&& | |Common Name=&&20-hydroxy Prostaglandin E_2&&9-oxo-11alpha,15S,20-trihydroxy-prosta-5Z,13E-dien-1-oic acid&& | ||
|Source=20-hydroxy PGE2 is a product of cytochrome P450 metabolism of PGE2.[[Reference:Oliw_EH:,Biochim. Biophys. Acta,1989,1001,107|{{RelationTable/GetFirstAuthor|Reference:Oliw_EH:,Biochim. Biophys. Acta,1989,1001,107}}]][[Reference:Oliw_EH:Fahlstadius_P:Hamberg_M:,J. Biol. Chem.,1986,261,9216|{{RelationTable/GetFirstAuthor|Reference:Oliw_EH:Fahlstadius_P:Hamberg_M:,J. Biol. Chem.,1986,261,9216}}]];> | |||
|Chemical Synthesis= | |||
|Metabolism= | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 22:00, 24 November 2009
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1714 |
| LipidMaps | LMFA03010014 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG30 |
| 20-hydroxy Prostaglandin E2 | |
|---|---|
| |
| Structural Information | |
| 9-oxo-11α,15S,20-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
| Formula | C20H32O6 |
| Exact Mass | 368.219888756 |
| Average Mass | 368.46448 |
| SMILES | C(CCC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)CO |
| Physicochemical Information | |
| 20-hydroxy PGE2 is a product of cytochrome P450 metabolism of PGE2. Oliw_EH Oliw_EH et al.;> | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
